Overview
Michael Sherman is a Hematologist Oncology specialist and a Hematologist in Danville, California. Dr. Sherman is rated as an Experienced provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Familial Prostate Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1320 El Capitan Dr, Suite 330, Danville, CA 94526
500 Lennon Ln, Walnut Creek, CA 94598
Stanford Health Care
Lawrence Leung is a Hematologist and a Hematologist Oncology provider in Stanford, California. Dr. Leung is rated as an Advanced provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Antiphospholipid Syndrome, Pulmonary Embolism, Deep Vein Thrombosis, and Cavernous Sinus Thrombosis.
Ucsf Medical Group Business Services
Andrew Leavitt is a Hematologist in Berkeley, California. Dr. Leavitt is rated as a Distinguished provider by MediFind in the treatment of Antiphospholipid Syndrome. His top areas of expertise are Hemophilia A, Von Willebrand Disease (VWD), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.
Stanford Health Care
Beth Martin is a Hematologist in Stanford, California. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Antiphospholipid Syndrome. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Childhood Iron Deficiency AnemiaDr. Sherman isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Familial Colorectal CancerDr. Sherman isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Sherman isDistinguished. Learn about Familial Prostate Cancer.
- Paget Disease of the BreastDr. Sherman isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Sherman isAdvanced. Learn about Angiosarcoma.
- Angiosarcoma of the ScalpDr. Sherman isAdvanced. Learn about Angiosarcoma of the Scalp.
- Bone TumorDr. Sherman isAdvanced. Learn about Bone Tumor.
- Breast CancerDr. Sherman isAdvanced. Learn about Breast Cancer.
- Colorectal CancerDr. Sherman isAdvanced. Learn about Colorectal Cancer.
- Iron Deficiency AnemiaDr. Sherman isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acute Eosinophilic PneumoniaDr. Sherman isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Sherman isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Sherman isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Sherman isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Sherman isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Sherman isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.